Abstract
The Abl oncoproteins v-Abl and BCR-Abl can activate member of the signal transducers and activators of transcription (STAT) family of signaling proteins. The mechanisms by which these oncoproteins activate STATs appear to differ. In cells transformed by v-Abl, Janus kinase (JAK) tyrosine kinases are constitutively activated. In these cells, the v-Abl oncoprotein and the JAK kinases physically associate. Mapping of the JAK interaction domain in v-Abl demonstrates that amino acids within the carboxyl terminal region of v-Abl bind JAKs through a direct interaction. A mutant of v-Abl lacking this region does not bind or activate JAK 1 in vivo, fails to activate STAT proteins, does not induce cellular proliferation, and is less efficient in cellular transformation. Kinase inactive mutants of JAK 1 inhibit the ability of v-Abl to activate STATs, to induce cytokine-independent proliferation, and to transform bone marrow cells. Interestingly, these effects correlate with defects in the activation of several pathways by v-Abl including Akt, PI3-kinase, STATs, and Ras. These data suggest that Jak kinases may play an important role in v-Abl induced transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Banerjee A and Rothman P . 1998 J Immunol 161: 4611–4617
Berchtold S, Volarevic S, Moriggl R, Mercep M and Groner B . 1998 Mol Endocrinol 12: 556–567
Carlesso N, Frank DA and Griffin JD . 1996 J Exp Med 183: 811–820
Chai SK, Nichols GL and Rothman P . 1997 J Immunol 159: 4720–4728
Chaturvedi P, Sharma S and Reddy EP . 1997 Mol Cell Biol 17: 3295–3304
Chen YY, Wang LC, Huang MS and Rosenberg M . 1994 Genes Dev 8: 688–697
Corcoran AE, Riddell A, Krooshoop D and Venkitaraman AR . 1998 Nature 391: 904–907
Danial NN, Losman JA, Lu T, Yip N, Krishnan K, Krolewski J, Goff SP, Wang JY and Rothman PB . 1998 Mol Cell Biol 18: 6795–6804
Danial NN, Pernis A and Rothman PB . 1995 Science 269: 1875–1877
Dorsch M and Goff SP . 1996 Proc Natl Acad Sci 93: 131131–131136
Fainstein E, Einat M, Gokkel E, Marcelle C, Croce CM, Gale RP and Canaani E . 1989 Oncogene 4: 1477–1481
Feller SM, Knudsen B and Hanafusa H . 1994 EMBO J 13: 2341–2351
Fischer AG, Burdet C, Bunce C, Merkenschlager M and Ceredig R . 1995 Int Immunol 7: 415–423
Fisher AG, Burdet C, LeMeur M, Haasner D, Gerber P and Ceredig R . 1993 Leukemia 7Suppl 2: S66–S68
Fukanaga R, Ishizaka-Ikeda E, Pan CX, Seto Y and Nagata S . 1991 EMBO J 10: 2855–2865
Gires O, Kohlhuber F, Kilger E, Baumann M, Kieser A, Kaiser C, Zeidler R, Scheffer, B, Ueffing M and Hammerschmidt W . 1999 EMBO J 18: 3064–3073
Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON and Sawyers CL . 1995 Oncogene 11: 791–799
Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON and Gilliland DG . 1996a Mol Cell Biol 16: 4107–4116
Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M and Gilliland DG . 1996b Biochim Biophys Acta 1288: M7–M10
Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse J-F, Capiod J-C, Deloba J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697
Hanratty WP and Dearold CR . 1993 J Gen Genet 238: 33–37
Haque SJ, Harbor P, Tabrizi M, Yi T and Williams BR . 1998 J Biol Chem 273: 33893–33896
Hardin JD, Boast S, Schwartzberg PL, Lee G, Alt FW, Stall AM and Goff SP . 1995 Cell Immunol 165: 44–54
Harrison DA, Binari R, Nahreini TS, Gilman M and Perrimon N . 1995 EMBO J 14: 2857–2865
Henderson YC, Guo XY, Greenberger J and Deisseroth AB . 1997 Clin Cancer Res 3: 145–149
Hevezi P, Alin K and Goff SP . 1993 Oncogene 8: 2413–2423
Hilbert DM, Theisen PW, Rudikoff EK and Bauer SR . 1998 Oncogene 17: 2125–2135
Hilton DJ . 1999 Cell Mol Life Sci 55: 1568–1577
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364
Ilaria J, RL and Van Etten RA . 1996 J Biol Chem 271: 31704–31710
Kadlec L and Pendergast AM . 1997 Proc Natl Acad Sci USA 94: 12390–12395
Kamura T, Sato S, Haque D, Liu L, Kaelin Jr WG, Conaway RC and Conaway JW . 1998 Genes Dev 12: 3872–3881
Kanwar VS, Witthuhn B, Campana D and Ihle JN . 1996 Blood 87: 4911–4912
Kipreos ET and Wang JYJ . 1992 Science 256: 382–385
Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO and Aaronson SA . 1986 Science 234: 1545–1548
Laneuville P . 1995 Semin Immunol 7: 255–266
Li S, Ilaria Jr RL, Million RP, Daley GQ and Van Etten RA . 1999 J Exp Med 189: 1399–1412
Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM, D'Andrea AD and Dearolf CR . 1997 Mol Cell Biol 17: 1562–1571
Marrero MB, Venema VJ, Ju H, Eaton DC and Venema RC . 1998 Am J Physiol 275: C1216–C1223
McWhirter JR and Wang JY . 1997 Oncogene 15: 1625–1634
McWhirter JR and Wang JYJ . 1991 Mol Cell Biol 11: 1553–1565
Melchers F, Rolink A, Grawunder U, Winkler TH, Karasuyama H, Ghia P and Andersson J . 1995 Curr Opin Immunol 7: 214–227
Miura O, Cleveland JL and Ihle JN . 1993 Mol Cell Biol 13: 1788–1795
Murata T and Puri RK . 1997 Cell Immunol 175: 33–40
Murtach K, Skladany G, Hoag J and Rosenberg N . 1986 J Virol 60: 599–606
Narazaki M, Fujimoto M, Matsumoto T, Morita Y, Saito H, Kajita T, Yoshizaki K, Naka T and Kishimoto T . 1998 Proc Natl Acad Sci USA 95: 13130–13134
Neel BG and Tonks NK . 1997 Curr Opin Cell Biol 9: 193–204
Nieborowoska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B and Skorski T . 1999 J Exp Med 189: 1229–1242
Oda T, Heaney C, Hagopian JR, Okuda K, Griffin JD and Druker BJ . 1994 J Biol Chem 269: 22925–22928
Ota J, Kimura F, Sato K, Wakimoto N, Nakamura Y, Nagata N, Suzu S, Yamada M, Shimamura S and Motoyoshi K . 1998 Biochem Biophys Res Commun 252: 779–786
Overell RW, Clark L, Lynch D, Jerzy R, Schmierer A, Weisser KE, Namen AE and Goodwin RG . 1991 Mol Cell Biol 11: 1590–1597
Ozaki K, Oda A, Wakao H, Rhodes J, Druker BJ, Ishida A, Wakui M, Okamoto S, Morita K, Handa M, Komatsu N, Ohashi H, Miyajima A and Ikeda Y . 1998 Blood 92: 4652–4662
Papadopoulos P, Ridge SA, Boucher CA, Stocking C and Wiedemann LM . 1995 Cancer Res 55: 34–38
Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Rompaey LV, Baens M, Van den Berghe H and Marynen P . 1997 Blood 90: 2535–2540
Pendergast AM, Quilliam LA, Cripe LD, Bassing GH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky M . 1993 Cell 75: 175–185
Pescheon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, et al. 1994 J Exp Med 180: 1955–1960
Prywes R, Foulkes JG, Rosenberg N and Baltimore D . 1983 Cell 34: 569–579
Raitano AB, Halpern JR, Hambuch TM and Sawyers CL . 1995 Proc Natl Acad Sci USA 92: 11746–11750
Rosenberg N . 1994 Sem Cancer Biol 5: 95–102
Rosenberg N and Witte ON . 1998 Adv Virus Res 35: 39–81
Rosenberg NE, Clark DR and Witte ON . 1980 J Virol 36: 766–774
Sawyers CL, Callahan W and Witte ON . 1992 Cell 70: 901–910
Sawyers CL, McLaughlin J and Witte ON . 1995 J Exp Med 181: 307–313
Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria Jr R, Marynen P and Gilliland DG . 1998 EMBO J 17: 5321–5333
Schwartzberg P, Stall M, Hardin J, Bowdish K, Humaran T, Boast S, Harbison ML, Robertson E and Goff SP . 1991 Cell 65: 1165–1175
Shuai K . 1999 Prog Biophys Mol Biol 71: 405–422
Shuai K, Halpern J, Hoeve JT, Rao X and Sawyers CL . 1996 Oncogene 13: 247–254
Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN and Calabretta B . 1997 EMBO J 16: 6151–6161
Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT and Mullingan RC . 1991 Cell 65: 1153–1163
Van Etten RA, Jackson P and Baltimore D . 1989a Cell 58: 669–678
Van Etten RA, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT and Janmey PA . 1989b J Cell Biol 124: 325–340
von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE and Murray R . 1995 J Exp Med 181: 1519–1526
Wang JY, Ledley F, Goff S, Lee R, Groner Y and Baltimore D . 1984 Cell 36: 349–356
Warmuth M, Bergmann M, Priess A, Hauslmann K, Emmerich B and Hallek M . 1997 J Biol Chem 272: 33260–33270
Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R and Finke J . 1996 Blood 88: 809–816
Wilson-Rawls J, Xie S, Liu J, Laneuville P and Arlinghaus RB . 1996 Cancer Res 56: 3426–3430
Yasunaga M, Wang F, Kunisada T and Nishikawa S . 1995 J Exp Med 182: 315–323
Yin T, Shen R, Feng GS and Yang YC . 1997 J Biol Chem 272: 1032–1037
Young JC, Gishizky ML and Witte ON . 1991 Mol Cell Biol 11: 854–863
Zou X and Calame K . 1999 J Biol Chem 274: 18141–18144
Acknowledgements
We would like to acknowledge our collaboration with Drs Stephen Goff and Kathryn Calame at Columbia University, Naomi Rosenberg (Tufts University), and Jean Wang (UC San Diego) in the Abl field, and Christian Schindler (Columbia University) in the JAK-STAT field. This work has been supported by The Leukemia Society of America, Cancer Research Institute, and by the National Cancer Institute.
Author information
Authors and Affiliations
Rights and permissions
This article is cited by
-
CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity
Cell Death & Differentiation (2020)
-
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease
Leukemia (2020)
-
Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway
Molecular Cancer (2019)
-
USP10 modulates the SKP2/Bcr-Abl axis via stabilizing SKP2 in chronic myeloid leukemia
Cell Discovery (2019)
-
Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth
Journal of Neuro-Oncology (2019)